Nanalysis Scientific Corp (NSCIF)
0.3378
+0.01
(+2.38%)
USD |
OTCM |
May 20, 11:31
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 38.02M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -13.16% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 1.590 |
Price to Book Value | 2.148 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.8112 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | -- |
Profile
Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company’s original product, the 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. The Company’s activities are carried out through three operating segments, within which are two reportable segments which include Scientific Equipment which includes sales of proprietary and third-party products and Security Services involves maintenance and installation of security equipment. Geographic segments of the group are the U.S., Europe, Canada, Asia, and Other regions. |
URL | https://www.nanalysis.com |
Investor Relations URL | N/A |
HQ State/Province | Alberta |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company’s original product, the 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. The Company’s activities are carried out through three operating segments, within which are two reportable segments which include Scientific Equipment which includes sales of proprietary and third-party products and Security Services involves maintenance and installation of security equipment. Geographic segments of the group are the U.S., Europe, Canada, Asia, and Other regions. |
URL | https://www.nanalysis.com |
Investor Relations URL | N/A |
HQ State/Province | Alberta |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |